Biomarin Pharmaceutical reported $382.03M in Operating Expenses for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Acadia Pharmaceuticals ACAD:US $ 228.48M 53.07M
Acorda Therapeutics ACOR:US $ 39.24M 9.29M
Agios Pharmaceuticals AGIO:US $ 99.27M 2.91M
Alnylam Pharmaceuticals ALNY:US $ 359.99M 93.1M
Amgen AMGN:US $ 3.74B 804M
Bayer BAYN:GR 10.43B 1.33B
Biogen BIIB:US $ 1921.1M 225.6M
Biomarin Pharmaceutical BMRN:US $ 382.03M 133.66M
Bluebird Bio BLUE:US $ 122.29M 14.98M
Gilead Sciences GILD:US $ 6393M 89M
Insmed INSM:US $ 142.94M 12.26M
Intercept Pharmaceuticals ICPT:US $ 98.85M 14.42M
IONIS PHARMACEUT IONS:US $ 199.42M 19.98M
Moderna Inc MRNA:US 1.84B 38M
Neurocrine Biosciences NBIX:US $ 307.5M 40.8M
Ptc Therapeutics PTCT:US $ 235.26M 14.7M
Puma Biotechnology PBYI:US $ 46.5M 1.83M
Regeneron Pharmaceuticals REGN:US $ 1706.6M 605.4M
Sangamo Biosciences SGMO:US $ 73.49M 5.61M
Sarepta Therapeutics SRPT:US $ 297.71M 9.56M
Seattle Genetics SGEN:US $ 559.51M 42.41M
Ultragenyx Pharmaceutical RARE:US $ 216.57M 30.61M
United Therapeutics UTHR:US $ 175.6M 69.8M
Vertex Pharmaceuticals VRTX:US $ 1056.6M 138.24M
YTE INCY:US $ 616.69M 135.42M